On Thursday, the Canadian government approved the use of Covifenz, the world’s first plant-based COVID-19 vaccine, jointly developed by Medicago Inc., a biopharma company owned by Mitsubishi Chemical and Philip Morris, situated in Quebec City, and GlaxoSmithKline Plc.First plant-based COVID vaccine: All you need to know
On Thursday, the Canadian government approved the use of Covifenz, the world’s first plant-based COVID-19 vaccine, jointly developed by Medicago Inc., a biopharma company owned by Mitsubishi Chemical and Philip Morris, situated in Quebec City, and GlaxoSmithKline Plc.
